Mometasone furoate: Efficacy and safety in moderate asthma compared with beclomethasone dipropionate

Annals of Allergy, Asthma and Immunology

Volumn 86, Issue 2, 2001, Pages 203-210

  Nathan, Robert A ^a,b   Nayak, Anjuli S ^c,d   Graft, David F ^e,f   Lawrence, Michael ^g   Picone, Frank J ^h   Ahmed, Tahir ⁱ   Wolfe, James ^b   Vanderwalker, Mark L ^d   Nolop, Keith B ^f   Harrison, Judy E ^f  

^a Asthma & Allergy Associates PC and Research Center   (United States)

^b Allergy & Asthma Associates of Northern California   (United States)

^c Allergy and Asthma Research Associates   (United States)

^d Clinical Research of the Ozarks   (United States)

^e PARK NICOLLET CLINIC   (United States)

^f MERCK RESEARCH LABORATORIES   (United States)

^g Center for Clinical Research   (United States)

^h Allergy and Asthma Consultants   (United States)

ⁱ MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; GLUCOCORTICOID; MOMETASONE FUROATE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; PEAK EXPIRATORY FLOW; POWDER INHALER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL ANALYSIS;

EID: 0035117821     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62692-0     Document Type: Article

References (24)

1. The British guidelines on asthma management 1995 review and position statement
2. A comparison of the efficacy and safety of inhaled corticosteroids in asthma
3. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial
4. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children
5. Airway remodeling and persistent airway obstruction in asthma
6. Adverse effects of inhaled corticosteroids
7. Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics
8. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids
9. + T cells
10. Cytokine inhibition by a novel steroid, mometasone furoate
11. Glucocorticoids inhibit proliferation and interleukin-4 and interleukin 5 secretion by aeroallergen-specific T-helper type 2 cell lines
12. Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders
13. Safety and efficacy of mometasone furoate cream in the treatment of steroid responsive dermatoses
14. Once-dally mometasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis: An active- and placebo-controlled study
15. A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray
16. Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients
17. Lack of systemic activity with intranasal mometasone furoate
18. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma
19. Dose-ranging study of a new steroid for asthma: Mometasone furoate dry powder inhaler
20. Assessment of dose uniformity with the new mometasone furoate dry powder inhaler (MF-DPI)
21. Comparison of mometasone furoate dry powder inhaler (MF-DPI) with Turbohaler using a new methodology for in vitro analysis of inhaler performance
22. Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses